Gastric hemorrhage in dogs given high doses of methylprednisolone sodium succinate

C R Rohrer1, R C Hill, A Fischer

  • 1Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville 32610-0126, USA.

Abstract

Insights

High doses of methylprednisolone sodium succinate (MPSS) caused severe gastric hemorrhage in healthy dogs. Veterinarians should consider protective treatments for dogs receiving high-dose MPSS to prevent gastrointestinal bleeding.

Area of Science:

  • Veterinary Medicine
  • Pharmacology
  • Gastroenterology

Background:

  • Corticosteroids like methylprednisolone sodium succinate (MPSS) are widely used in veterinary medicine.
  • Potential adverse effects on the gastrointestinal tract require thorough investigation.

Purpose of the Study:

  • To evaluate the gastrointestinal effects of high-dose MPSS in healthy dogs.
  • To determine the incidence of ulcers and hemorrhage following MPSS administration.

Main Methods:

  • Nineteen healthy hound-type dogs were used in a randomized study.
  • Dogs received either high-dose MPSS intravenously or a saline control for 48 hours.
  • Gastroduodenoscopy, pH measurement, and occult blood testing were performed.

Main Results:

  • All MPSS-treated dogs exhibited gastric hemorrhage, with 90% showing severe signs.
  • MPSS administration led to increased gastric acidity and common food retention.
  • Occult gastric blood was significantly more prevalent in the MPSS group.

Conclusions:

  • High-dose MPSS administration is strongly associated with gastric hemorrhage in dogs.
  • Prophylactic use of mucosal protectants or antacids is recommended for dogs receiving high-dose MPSS.
  • This study highlights the critical need for gastrointestinal protection during high-dose corticosteroid therapy in canines.

Related Concept Videos

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current medication...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...